T2加权乳腺MRI乳腺水肿分级有助于诊断隐匿性炎性乳腺癌并预测新辅助化疗后预后
回顾性纳入2011年1月至2018年12月接受乳腺MRI并接受新辅助化疗的408例乳腺癌女性,按T2加权图像将乳腺水肿分为BES 1–4级,临床明显炎性乳腺癌归为BES 5。BES与无进展生存和总生存相关,BES 4提示可疑隐匿性炎性乳腺癌。
要点
- T2加权MRI上乳腺水肿按BES 1–4级评分,BES 4为皮下水肿,可疑隐匿性炎性乳腺癌。
- BES 1–5级100个月无进展生存率分别为0.92、0.85、0.80、0.62、0.58。
- BES 1–5级100个月总生存率分别为0.98、0.91、0.92、0.77、0.86。
关键影像表现/征象
- T2加权图像上乳腺水肿评分为1–4级:BES 1无水肿,BES 2瘤周水肿,BES 3胸前水肿,BES 4皮下水肿(可疑隐匿性炎性乳腺癌)。
- 临床明显炎性乳腺癌不行MRI,归为BES 5。
诊断标准与关键数值
- BES 1–5级100个月无进展生存率分别为0.92、0.85、0.80、0.62、0.58。
- BES 1–5级100个月总生存率分别为0.98、0.91、0.92、0.77、0.86。
- Log-rank检验显示BES 4 vs 1、BES 5 vs 1、BES 5 vs 2、BES 5 vs 3的无进展生存差异有统计学意义(校正P < .05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Prediction of occult inflammatory breast cancer (IBC) and breast cancer prognosis based on breast edema findings on T2-weighted MRI scans, even for patients without clinical signs of IBC, would be useful in both pretreatment planning and prognosis and may elucidate the underlying biologic mechanisms. Purpose To evaluate whether classification of breast edema on T2-weighted MRI scans is useful for predicting the prognosis of patients with breast cancer treated with neoadjuvant chemotherapy (NAC). Materials and Methods A retrospective evaluation was performed of women with breast cancer who underwent breast MRI and were treated with NAC between January 2011 and December 2018. Breast edema on T2-weighted images was scored on a scale of 1 to 4, as follows: (a) breast edema score (BES) 1, no edema; (b) BES 2, peritumoral edema; (c) BES 3, prepectoral edema; and (d) BES 4, subcutaneous edema (suspicious for occult IBC). Clinically evident IBC was classified as BES 5 (without MRI). The log-rank test was performed, and hazard ratios were calculated using the Cox hazard model to evaluate associations between BES and progression-free survival (PFS) and overall survival (OS). PFS rate at 100 months after initiation of therapy was also evaluated. Results Of 408 patients (median age, 53 years; range, 28-80 years), 65 (16%) had a recurrence and 27 (7%) died. The log-rank test revealed differences in PFS for BES 4 versus 1, BES 5 versus 1, BES 5 versus 2, and BES 5 versus 3 (adjusted P < .05 for all). PFS rates for BES 1-5 were 0.92, 0.85, 0.80, 0.62, and 0.58, respectively, and the corresponding OS rates at 100 months were 0.98, 0.91, 0.92, 0.77, 0.86, respectively. Conclusion Classification of breast edema findings on T2-weighted MRI scans using a breast edema score was related to the prognosis of patients after neoadjuvant chemotherapy. © RSNA, 2021 Online supplemental material is available for this article.
引用
- Harada TL, Uematsu T, Nakashima K, et al. Evaluation of Breast Edema Findings at T2-weighted Breast MRI Is Useful for Diagnosing Occult Inflammatory Breast Cancer and Can Predict Prognosis after Neoadjuvant Chemotherapy. Radiology. 2021. PMID: 33560188. doi:10.1148/radiol.2021202604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。